Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/03/19/2848533/25687/en/ClearPoint-Neuro-Congratulates-its-Partner-PTC-Therapeutics-on-Completion-of-Biologics-License-Application-Submission-to-FDA-for-Upstaza-as-a-Treatment-for-AADC-Deficiency.html
https://www.globenewswire.com//news-release/2024/03/12/2845015/25687/en/ClearPoint-Neuro-Reports-Fourth-Quarter-and-Full-Year-2023-Results.html
https://www.globenewswire.com//news-release/2024/03/11/2843745/25687/en/Journal-of-Neurosurgery-Publication-Demonstrates-Distinct-Advantages-of-ClearPoint-Prism-Neuro-Laser-Therapy-System.html
https://www.globenewswire.com//news-release/2024/03/01/2839062/25687/en/ClearPoint-Neuro-to-Announce-Fourth-Quarter-and-Full-Year-2023-Results-March-12-2024.html
https://www.globenewswire.com//news-release/2024/02/29/2837909/25687/en/ClearPoint-Neuro-Announces-Pricing-of-Public-Offering-of-2-307-694-Shares-of-Common-Stock.html
https://www.globenewswire.com//news-release/2024/02/28/2837496/25687/en/ClearPoint-Neuro-Launches-Proposed-Public-Offering-of-Common-Stock.html
https://www.globenewswire.com//news-release/2024/02/21/2833130/25687/en/ClearPoint-Neuro-Announces-FDA-Clearance-and-First-in-Human-Cases-Performed-with-the-New-2-2-Software-Version-and-the-Integrated-Maestro-Brain-Model.html
https://www.globenewswire.com//news-release/2024/01/24/2816060/25687/en/ClearPoint-Neuro-Announces-Installation-and-First-Procedure-Using-the-ClearPoint-Prism-Neuro-Laser-Therapy-System-and-Navigation-System-at-Kaleida-Health-in-Buffalo.html
https://www.globenewswire.com//news-release/2024/01/22/2813460/25687/en/ClearPoint-Neuro-Announces-First-EU-MDR-Certification-Success-and-Approval-to-Ship-Product-to-Europe.html
https://www.globenewswire.com//news-release/2024/01/16/2809835/25687/en/ClearPoint-Neuro-Announces-FDA-Clearance-for-SmartFrame-OR-Stereotactic-System.html